| Mrs Tara Ann Peregrim, MS CCC-SLP | |
|
2300 Adams Ave, Scranton, PA 18509-1514 | |
| (570) 348-6299 | |
| (570) 961-4708 |
| Full Name | Mrs Tara Ann Peregrim |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2300 Adams Ave, Scranton, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164705083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL005846L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tara Ann Peregrim, MS CCC-SLP 2300 Adams Ave, Scranton, PA 18509-1514 Ph: (570) 348-6299 | Mrs Tara Ann Peregrim, MS CCC-SLP 2300 Adams Ave, Scranton, PA 18509-1514 Ph: (570) 348-6299 |
News Archive
A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy.
A new UK study available on the preprint server medRxiv screened 2.4 million users of a symptom reporting application during the coronavirus disease (COVID-19) pandemic, revealing that smokers are at higher risk of increased symptom burden and more prone to hospitalization.
Optimer Pharmaceuticals, Inc. today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Optimer.
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. Their study results were published online today in Cancer Cell.
› Verified 7 days ago
Renee Linda Hurwitz, M.A., CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 N Washington Ave, Scranton, PA 18509 Phone: 570-267-5080 Fax: 570-696-0172 | |
Enrichment Therapy Services Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 35 Pen Y Bryn Dr, Scranton, PA 18505 Phone: 570-209-5939 | |
Kara F Medeiros, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Adams Ave, Mcgowan Center, Scranton, PA 18509 Phone: 570-348-6299 | |
Cassandra Michaylo, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 401 Penn Ave, Scranton, PA 18503 Phone: 570-961-4300 | |
Rebecca Ann Bozym, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 324 Alder St, Scranton, PA 18505 Phone: 570-972-7593 | |
Dr. Bruce Wisenburn, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2300 Adams Ave, Marywood University, Scranton, PA 18509 Phone: 570-348-6299 Fax: 570-961-4708 | |
Kathleen Klatt, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2010 Adams Ave, Scranton, PA 18509 Phone: 570-963-1278 Fax: 570-963-1292 |